7,698.51

+129.59

+1.71%

53,247.86

+1,461.14

+2.82%

25,857.77

+485.76

+1.91%

2,851.09

+38.65

+1.37%

4.8940

-0.0580

-1.17%

17.29

-3.54

-16.98%

4,072.70

+132.30

+3.36%

80,345.60

+2,795.06

+3.60%

Crude Oil Dec 26

88.36

-7.73

-8.04%

US Private Equity

10,855.23

+18.94

+0.17%

Swiss CHF

Roche Holding AG (RO.SW)

401.60 +2.60 (+0.65%)

At close: 5:31:16 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

CORT's Q3 Earnings Beat, Higher Product Sales Aid Y/Y Revenues

Zacks 2h ago

CORT

RHHBF

TGTX
Zymeworks (ZYME) Gains Fresh Backing On Trial Data And Roche Deal

Simply Wall St. 12h ago

ZYME

ROP.SW
NRIX Slumps 35% After-Hours — What’s Driving The Selloff?

Stocktwits 18h ago

NRIX

SNY

ROP.SW
Madrigal Pharmaceuticals Inc (MDGL) Q3 2026 Earnings Call Highlights: First Profitable Quarter ...

GuruFocus.com 19h ago

MDGL

ROP.SW
Health Care Roundup: Market Talk

The Wall Street Journal 1d ago

ROP.SW
Roche Secures FDA Clearance for New cobas eplex Respiratory Panel Detecting Up to 19 Pathogens

InvestorsHub 2d ago

ROP.SW
SIG vs. CFRUY: Which Stock Is the Better Value Option?

Zacks 2d ago

SIG

CFRHF
UBS sees Roche giredestrant potential priced in after 50% share rally

Investing.com 2d ago

ROP.SW

ROPC

RO.SW
+0.65%
FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight

Stocktwits 2d ago

ROP.SW

ALNY

REGN
Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

Simply Wall St. 2d ago

NVS

ROP.SW

NOVN
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug

The Wall Street Journal 9d ago

ROP.SW

RVMD

AMGN
U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AI

Barrons.com 12d ago

AZN

RO.SW
+0.65%
MRK

Performance Overview

Return	RO.SW	MSCI WORLD (^990100-USD-STRD)
YTD	+23.73%	+10.61%
1-Year	+52.48%	+12.20%
3-Year	+75.80%	+71.00%

Mobilize your Website

View Site in Mobile | Classic

Share by: